CTTI Names Sally Okun as New Executive Director

CTTI Names Sally Okun as New Executive Director

[yoast-breadcrumb]

The Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by Duke University and the U.S. Food and Drug Administration (FDA), today announced Sally Okun as its new executive director.

Download Press Release